byiShook Opinion
Sep 10, 2024 - 10:50
Centessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday as the biotech stock surged on test results. The post Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity appeared first on Investor's Business Daily.
Centessa has a potential blockbuster narcolepsy treatment on its hands, an analyst said Tuesday as the biotech stock surged on test results.
The post Centessa Rockets To Three-Year High On $5 Billion Narcolepsy Opportunity appeared first on Investor's Business Daily.